4.3 Congenital anomalies of the nervous system: Microcephaly

PAGE 9 of 31

View Table of Contents

Microcephaly (microcephalus) describes a cranial vault that is smaller than normal for the infant’s sex and gestational age at birth (congenital). The size of the cranial vault is an indicator of the size of the underlying brain. Microcephaly can be diagnosed prenatally but is more often diagnosed after delivery. Fig. 4.12 shows newborns with normal head size, microcephaly, and severe microcephaly, and the correct position of a tape to measure the head circumference.

Fig. 4.12. Microcephaly

Microcephaly

Relevant ICD-10 codes

Q02 Microcephaly

Diagnosis

Prenatal. Transabdominal ultrasound between 18 and 37 weeks’gestation might identify a small head size, with serial ultrasounds showing poor growth over time. Measurement of the fetal head circumference (HC) and biparietal diameter should be made on the axial image through the thalami at the level of the cavum septi pellucidi.

Postnatal. At delivery, a measurement of the occipito-frontal circumference or HC that is three standard deviations below the mean for the age- and sex-appropriate distribution curves is diagnostic of severe microcephaly. See the link below on how best to measure HC at birth.

Report if using a different definition or cut-off point (e.g. two standard deviations below the mean).

Cranial ultrasound, CT or MRI scans can confirm the diagnosis of an underlying brain abnormality.

Clinical and epidemiologic notes

Timing of measurement. Although head molding and/or swelling can occur during the birthing process, HC measurements should be obtained within the first 24 hours of life. Standards for HC are based on early measurements (i.e. INTERGROWTH-21st measurements were obtained before 12 hours of life and WHO measurements were obtained before 24 hours of life). Therefore, postponing HC measurements until after 24 hours of life to allow for birth process changes to subside results in not having appropriate comparison standards.

Calculating the percentile of HC. The INTERGROWTH-21st project provides data on HC based on a multicenter, multi-ethnic and population-based project. The online tool (http://intergrowth21.ndog.ox.ac.uk)  can be used to enter data to calculate the percentile of the HC or to compare to standards based on the infant’s sex and gestational age (28).

Causes. Microcephaly is occasionally a normal trait in a family, so measuring parents’ HC if possible is reasonable. Many genetic syndromes are associated with microcephaly (> 1000 matches in www.OMIM.org) (29). Teratogenic conditions that can cause microcephaly include congenital rubella (P35.0), congenital cytomegalovirus (cCMV) (P35.1), congenital Zika (P35.4) and congenital toxoplasmosis (P37.1) infections. Detailed imaging and expert consultations (e.g. paediatric geneticist, paediatric neurologist) can help identify underlying causes of microcephaly.

Inclusions

Q02 Microcephaly

Exclusions

Small brain – without confirmation of HC measurement demonstrating microcephaly.

Microcephaly associated with anencephaly or encephalocele.

Acquired microcephaly; for example, secondary to a birth or delivery complication, postnatal insult or trauma, neonatal meningitis, and birth asphyxia.

Checklist for high-quality reporting

Microcephaly – Documentation Checklist
Describe in detail:
  • Measure and document HC in newborn.
  • Establish and use a standardized approach (e.g. follow standard rules for taking HC measurement within 24 hours after birth).
  • Document the HC percentile or standard deviation, by gestational age and sex [use the recommended references for HC provided by INTERGROWTH-21st (28) or WHO].
  • Distinguish microcephaly from craniosynostosis.
    • Take and report photographs: Show full face and body photographs, if allowed; can be crucial for review.
    • Describe evaluations to find or rule out related and associated anomalies:
        • Report neurologic status and signs (e.g. tone, seizures, irritability).
        • Report whether laboratory examinations (e.g. serology to identify infections) or specialty consultations (e.g. genetics) were done, and results.

Report whether autopsy (pathology) findings are available and if so, report the results.

Suggested data quality indicators

Category Suggested Practices and Quality Indicators
Description and documentation
  • Review sample for documentation of key descriptor (HC measurement).
  • Take and attach photographs – essential for review and correct classification.
  • Report and track proportion of cases among live births, stillbirths and pregnancy terminations.
Coding
  • Code as Q02.
Clinical classification
  • Track proportion of anomalies and syndromes occurring with microcephaly.
  • If the fetus was stillborn, or a pregnancy termination performed, check for a pathology report and physical description at delivery.
Prevalence
  • Monitor prevalence: Prevalence varies by country/region, country income level and race/ethnicity.

Table of Contents

  1. Chapter 4: Diagnosing and Coding Congenital Anomalies
  2. 4.1 List of Selected External and Internal Congenital Anomalies to Consider for Monitoring
  3. 4.2 Congenital Malformations of the Nervous System: Neural Tube Defects
  4. 4.2a Anencephaly
  5. 4.2b Craniorachischisis (Q00.1)
  6. 4.2c Iniencephaly (Q00.2)
  7. 4.2d Encephalocele (Q01.0–Q01.83, Q01.9)
  8. 4.2e Spina Bifida (Q05.0–Q05.9)
  9. 4.3 Congenital Anomalies of the Nervous System: Microcephaly
  10. 4.4 Congenital Malformations of the Ear
  11. 4.5a Overview Congenital Heart D: Prenatal Diagnosis and Postnatal Confirmation
  12. 4.5b Common Truncus (Q20.0)
  13. 4.5c Transposition of Great Arteries (Q20.3)
  14. 4.5d Tetralogy of Fallot
  15. 4.5e Pulmonary Valve Atresia (Q22.0)
  16. 4.5f Tricuspid Valve Atresia (Q22.4)
  17. 4.5g Hypoplastic Left Heart Syndrome (Q23.4)
  18. 4.5h Interrupted Aortic Arch (q25.21, Preferred; Also Q25.2, Q25.4)
  19. 4.6 Orofacial Clefts
  20. 4.7 Congenital Malformations of the Digestive System
  21. 4.8 Congenital Malformations of Genital Organs Hypospadias (Q54.0–Q54.9)
  22. 4.9a Congenital Malformations and Deformations of the Musculoskeletal System: Talipes Equinovarus (Q66.0)
  23. 4.9b Congenital Malformations and Deformations of the Musculoskeletal System: Limb Reduction Defects/Limb Deficiencies
  24. 4.9c Limb Deficiency Amelia (Q71.0, Q72.0, Q73.0)
  25. 4.9d Limb Deficiency: Transverse Terminal (Q71.2, Q71.3, Q71.30, Q72.2, Q72.3, Q72.30)
  26. 4.9e Limb Deficiency: Transverse Intercalary (Q71.1, Q72.1, Q72.4)
  27. 4.9f Limb Deficiency: Longitudinal Preaxial (Tibia, Radius, First Ray) (Q71.31, Q71.4, Q72.31, Q72.5)
  28. 4.9g Limb Deficiency: Longitudinal Postaxial (Fibula, Ulna, Fifth Ray) (Q71.30, Q71.5, Q72.30, Q72.6)
  29. 4.9h Limb Deficiency: Longitudinal Axial Limb Deficiency – Split Hand and Foot (Q71.6, Q72.7)
  30. 4.10 Abdominal Wall Defects
  31. 4.11 Chromosomal Abnormalities